Intuitive Surgical, Inc. $ISRG Shares Sold by Strs Ohio

Strs Ohio lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 140,989 shares of the medical equipment provider’s stock after selling 15,142 shares during the quarter. Strs Ohio’s holdings in Intuitive Surgical were worth $79,851,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in ISRG. Rakuten Investment Management Inc. acquired a new position in Intuitive Surgical in the 3rd quarter worth $388,436,000. Assenagon Asset Management S.A. lifted its holdings in Intuitive Surgical by 106.6% in the 4th quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock worth $868,667,000 after buying an additional 791,516 shares in the last quarter. Amundi lifted its holdings in Intuitive Surgical by 29.7% in the 3rd quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock worth $1,451,362,000 after buying an additional 739,444 shares in the last quarter. Sands Capital Management LLC lifted its holdings in Intuitive Surgical by 77.0% in the 3rd quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider’s stock worth $599,784,000 after buying an additional 583,539 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in Intuitive Surgical by 41.3% in the 3rd quarter. Victory Capital Management Inc. now owns 1,941,310 shares of the medical equipment provider’s stock worth $868,212,000 after buying an additional 567,483 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. Truist Financial dropped their target price on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Robert W. Baird boosted their target price on shares of Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Finally, Piper Sandler dropped their target price on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $581.91.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 2,362 shares of the company’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the transaction, the senior vice president owned 3,554 shares in the company, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the transaction, the director owned 239 shares of the company’s stock, valued at approximately $113,156.94. This trade represents a 67.66% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 5,906 shares of company stock worth $2,907,726 in the last quarter. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Up 0.0%

Shares of NASDAQ:ISRG opened at $457.78 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $427.84 and a fifty-two week high of $603.88. The firm has a 50-day simple moving average of $474.86 and a 200 day simple moving average of $515.98. The company has a market cap of $162.13 billion, a PE ratio of 55.49, a P/E/G ratio of 3.67 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the prior year, the firm earned $1.81 EPS. The company’s revenue for the quarter was up 23.0% compared to the same quarter last year. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 8.53 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.